Data-driven overdiagnosis definitions: A scoping review.

Digital health innovations offer significant potential to transform clinical care and patient management strategies. However, the rapid integration of these technologies into healthcare systems presents unique challenges for patient safety. No prior work had resolved the ambiguity surrounding adverse outcomes when applying these tools to asymptomatic populations. Overdiagnosis remains a significant concern as diagnostic capabilities expand through advanced computational approaches. That uncertainty drove the need to evaluate how current literature defines and quantifies this phenomenon. Researchers have struggled to establish uniform metrics for identifying patients who receive unnecessary diagnoses. This gap motivated a systematic investigation into existing quantitative strategies used across various medical fields. Understanding these definitions is vital for ensuring that technological progress does not inadvertently harm patients.

The aim of this scoping review is to comprehensively analyze quantification strategies and data-driven definitions for overdiagnosis reported in the literature. Researchers seek to understand how these definitions vary across different clinical contexts and diagnostic approaches. This investigation addresses the challenge of translating digital health innovations into improved patient care without causing unintended harm. The authors focus on the potential adverse effects of applying diagnostic tools to healthier segments of the population. They identify a clear need to evaluate existing methods for estimating the proportion of overdiagnosed patients. This study motivates a deeper look at how current quantitative techniques influence our understanding of diagnostic accuracy. By mapping the available evidence, the team intends to highlight the lack of a consistent standard in the field. The work ultimately serves to inform future efforts in developing more reliable metrics for diagnostic safety.

The authors performed a scoping systematic review to identify manuscripts describing quantitative strategies for estimating overdiagnosis. Their search approach targeted studies that provided numerical methods for calculating the proportion of affected patients. Researchers established specific inclusion criteria to select relevant literature from a broad range of clinical domains. The team analyzed 46 manuscripts that met these predefined requirements for quantitative rigor. This review process involved examining both prospective and retrospective study designs to capture diverse measurement techniques. Investigators included randomized clinical trials and various simulation models to ensure a comprehensive overview of the field. The study design focused on mapping the landscape of existing definitions rather than conducting a new primary analysis. This systematic approach allowed the authors to categorize the different ways that researchers currently quantify diagnostic outcomes.

The authors identified 46 studies that met their criteria for analyzing quantitative methods of overdiagnosis. These manuscripts covered a wide variety of clinical conditions, with breast and prostate cancer appearing most frequently. The literature reveals that current strategies for quantifying overdiagnosis produce widely diverging results across different studies. Researchers utilized both prospective and retrospective methods to estimate the proportion of overdiagnosed individuals. These quantitative approaches included randomized clinical trials and complex simulation models. The findings demonstrate that there is no standard method currently employed to measure this adverse effect. This lack of uniformity complicates the comparison of diagnostic outcomes across different digital health innovations. The results highlight a significant need for standardized metrics to improve the safety of emerging diagnostic technologies.

The authors emphasize that current literature lacks a unified standard for quantifying overdiagnosis across clinical settings. This synthesis suggests that the wide variation in reported metrics hinders effective mitigation strategies. Researchers propose that establishing a consistent definition is necessary to improve patient safety in digital health. The review highlights that existing quantitative approaches produce highly inconsistent findings when applied to patient data. Authors observe that the rapid development of diagnostic tools necessitates more rigorous evaluation of potential adverse effects. This analysis indicates that current methodologies for estimating overdiagnosis are fragmented and require standardization. The team concludes that future efforts should prioritize the development of reliable benchmarks for diagnostic accuracy. This work underscores the importance of addressing overdiagnosis to ensure that digital innovations provide genuine clinical benefits.